(Q27322781)
Statements
EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS (English)
0 references
2013
0 references
8
0 references
4
0 references
e62342
0 references
26 April 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference